GlassScriptPhysician profile
Matthew A Zaborowicz
NPI 1528596723
$1,778.30
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $508 · 2020: $140 · 2021: $155 · 2023: $975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $658 · Food and Beverage: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $657.67 |
| Food and Beverage | $317.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lightbody Medical Technologies INC | $565.72 | 2023 | |
| Arthrex, INC. | $278.08 | 2023 | |
| Abbvie INC. | $183.36 | 2019 | |
| Janssen Pharmaceuticals, INC | $168.82 | 2019-2020 | |
| Bioventus LLC | $155.06 | 2021 | |
| Zimmer Biomet Holdings, INC. | $131.11 | 2023 | Tapestry |
| Novartis Pharmaceuticals Corporation | $91.59 | 2019 | |
| Neurocrine Biosciences, INC. | $90.86 | 2019 | |
| Gilead Sciences, INC. | $79.63 | 2019 | |
| Novo Nordisk INC | $20.34 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Zaborowicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.